- Company
SR Score
76,084
SR Web
78,693
PAREXEL is a biopharmaceutical services company that focuses on the development and commercialization of new medical therapies worldwide.
Acquired by Pamplona Capital Management on June 20, 2017
We simplify our clients’ journey of transforming scientific discoveries into new medical treatments for patients by delivering comprehensive and high-quality Phase I-IV clinical research, regulatory, consulting and market access s
See More
Website: https://www.parexel.com
Founded: January 01, 1983
Social:
